CIK 0001812364 · Large accelerated filer
Relay Therapeutics, Inc.
Sign in to watch- Ticker
- RLAY
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 617-370-8837
- Business address
- 60 HAMPSHIRE STREET, CAMBRIDGE, MA, 02139
- 10-Q Report Quarterly Report
- 8-K Event Results of operations · Regulation FD disclosure
- 4 Open-market sale See remarks sold 1,352 shares at $11.80 ($15,954)
- 4 Open-market sale Chief Financial Officer sold 1,693 shares at $11.80 ($19,977)
- 4 Open-market sale President, R&D sold 2,683 shares at $11.80 ($31,659)
- 4 Open-market sale Chief Legal Officer sold 1,628 shares at $11.80 ($19,210)
- SC 13G/A Stake Amended Statement of Ownership
- 4 Open-market sale See remarks sold 244 shares at $12.12 ($2,957)
- 4 Open-market sale Chief Financial Officer sold 294 shares at $12.12 ($3,563)
- 4 Open-market sale President, R&D sold 647 shares at $12.12 ($7,842)
- 4 Open-market sale Chief Legal Officer sold 294 shares at $12.12 ($3,563)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Grant or award See remarks acquired 161,818 shares (grant or award)
- 4/A Open-market sale See remarks sold 1,657 shares at $11.16 ($18,492)
Page 15 of 28 · 556 filings